General Information of the Compound
Compound ID |
CP0390790
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
6-[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenoxy]-N-hydroxyhexanamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C33H36N2O10
|
||||||||||||||||||
Molecular Weight |
620.655
|
||||||||||||||||||
Canonical SMILES |
COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](Nc2ccccc2OCCCCCC(=O)NO)c2cc3OCOc3cc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C33H36N2O10/c1-40-26-12-18(13-27(41-2)32(26)37)29-19-14-24-25(45-17-44-24)15-20(19)31(21-16-43-33(38)30(21)29)34-22-8-5-6-9-23(22)42-11-7-3-4-10-28(36)35-39/h5-6,8-9,12-15,21,29-31,34,37,39H,3-4,7,10-11,16-17H2,1-2H3,(H,35,36)/t21-,29+,30-,31+/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
REKPBEKUNFMZNT-WVGCQFFWSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT00995, Histone deacetylase 3
Protein ID: PT01213, Histone deacetylase 6